Your browser doesn't support javascript.
loading
Mutual information for detecting multi-class biomarkers when integrating multiple bulk or single-cell transcriptomic studies.
Zou, Jian; Li, Zheqi; Carleton, Neil; Oesterreich, Steffi; Lee, Adrian V; Tseng, George C.
Afiliación
  • Zou J; Department of Statistics, School of Public Health, Chongqing Medical University, Chongqing, 400016, Chongqing, China.
  • Li Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 02215, Massachusetts, USA.
  • Carleton N; Department of Medicine, Harvard Medical School, Boston, 02215, Massachusetts, USA.
  • Oesterreich S; Women's Cancer Research Center, UPMC Hillman Cancer Center (HCC), Pittsburgh, 15232, Pennsylvania, USA.
  • Lee AV; Magee-Womens Research Institute, Pittsburgh, 15213, Pennsylvania, USA.
  • Tseng GC; Medical Scientist Training Program, School of Medicine, University of Pittsburgh, Pittsburgh, 15213, Pennsylvania, USA.
bioRxiv ; 2024 Jun 13.
Article en En | MEDLINE | ID: mdl-38915481
ABSTRACT
Motivation Biomarker detection plays a pivotal role in biomedical research. Integrating omics studies from multiple cohorts can enhance statistical power, accuracy and robustness of the detection results. However, existing methods for horizontally combining omics studies are mostly designed for two-class scenarios (e.g., cases versus controls) and are not directly applicable for studies with multi-class design (e.g., samples from multiple disease subtypes, treatments, tissues, or cell types).

Results:

We propose a statistical framework, namely Mutual Information Concordance Analysis (MICA), to detect biomarkers with concordant multi-class expression pattern across multiple omics studies from an information theoretic perspective. Our approach first detects biomarkers with concordant multi-class patterns across partial or all of the omics studies using a global test by mutual information. A post hoc analysis is then performed for each detected biomarkers and identify studies with concordant pattern. Extensive simulations demonstrate improved accuracy and successful false discovery rate control of MICA compared to an existing MCC method. The method is then applied to two practical scenarios four tissues of mouse metabolism-related transcriptomic studies, and three sources of estrogen treatment expression profiles. Detected biomarkers by MICA show intriguing biological insights and functional annotations. Additionally, we implemented MICA for single-cell RNA-Seq data for tumor progression biomarkers, highlighting critical roles of ribosomal function in the tumor microenvironment of triple-negative breast cancer and underscoring the potential of MICA for detecting novel therapeutic targets.

Availability:

https//github.com/jianzou75/MICA.

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2024 Tipo del documento: Article País de afiliación: China